Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL cholesterol.
Researchers from Curtin University in Australia and multiple universities in Ethiopia report that prenatal folic acid and multivitamin supplementation is associated with a roughly 30% lower risk of autism spectrum disorder ...
Temporarily anesthetizing the retina briefly reverts the activity of the visual system to that observed in early development and enables growth of responses to the amblyopic eye, new research shows.
18 hours ago
0
63
A multi-country clinical trial has shown that a structured, sustainable approach to infection prevention and treatment can save women's lives, cutting severe maternal infections and deaths by about one-third (32%) compared ...
16 hours ago
0
5
A new analytical tool can improve a hospital's ability to limit the spread of antibiotic-resistant infections over traditional methods like contact tracing, according to a new study led by researchers at Columbia University ...
16 hours ago
0
0
Immunotherapy, which harnesses our body's own immune system to fight cancer, has revolutionized modern oncology. Yet despite its success with several cancers, many patients still fail to respond to therapy or experience relapse ...
20 hours ago
0
32
A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, reported in a paper published in Nature, suggest a potential alternative to injection for diabetes ...
11 hours ago
0
3
Columbia University researchers are the first to show that focused ultrasound—a noninvasive technique that uses sound waves to enhance the delivery of drugs into the brain—can be safely used in children being treated ...
18 hours ago
0
0
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms driving treatment resistance ...
19 hours ago
0
5
A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing strategy that could potentially lead to a one-time treatment for multiple unrelated genetic diseases.
18 hours ago
0
0
